Novel Zebrafish Patient-Derived Tumor Xenograft Methodology for Evaluating Efficacy of Immune-Stimulating BCG Therapy in Urinary Bladder Cancer.
- DOI
- 10.3390/cells12030508
- Published
- 2023 Feb 3
- Container
- Cells
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/cells12030508,
title = {Novel Zebrafish Patient-Derived Tumor Xenograft Methodology for Evaluating Efficacy of Immune-Stimulating BCG Therapy in Urinary Bladder Cancer.},
author = {Kowald S and Huge Y and Tandiono D and Ali Z and Vazquez-Rodriguez G and Erkstam A and Fahlgren A and Sherif A and Cao Y and Jensen LD},
year = {2023},
journal = {Cells},
doi = {10.3390/cells12030508},
url = {https://doi.org/10.3390/cells12030508}
}RIS
TY - JOUR TI - Novel Zebrafish Patient-Derived Tumor Xenograft Methodology for Evaluating Efficacy of Immune-Stimulating BCG Therapy in Urinary Bladder Cancer. AU - Kowald S AU - Huge Y AU - Tandiono D AU - Ali Z AU - Vazquez-Rodriguez G AU - Erkstam A AU - Fahlgren A AU - Sherif A AU - Cao Y AU - Jensen LD PY - 2023 JO - Cells DO - 10.3390/cells12030508 UR - https://doi.org/10.3390/cells12030508 ER -
APA
S, K., Y, H., D, T., Z, A., G, V., A, E., A, F., A, S., Y, C., & LD, J. (2023). Novel Zebrafish Patient-Derived Tumor Xenograft Methodology for Evaluating Efficacy of Immune-Stimulating BCG Therapy in Urinary Bladder Cancer.. Cells. https://doi.org/10.3390/cells12030508
Source records
- pubmed · retrieved 2026-09-25T17:12:18.922Z